Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

Open Access 01-12-2020 | Opioids | Methodology

Implementation of strength-based case management for opioid-dependent patients presenting in medical emergency departments: rationale and study design of a randomized trial

Authors: Amber Regis, Sarah E. Meyers-Ohki, Sarah E. Mennenga, Peter P. Greco, Richard Glisker, Rhonda Kolaric, Ryan P. McCormack, Richard C. Rapp, Michael P. Bogenschutz

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

As the USA grapples with an opioid epidemic, medical emergency departments (EDs) have become a critical setting for intervening with opioid-dependent patients. Brief interventions designed to bridge the gap from acute ED care to longer-term treatment have shown limited efficacy for this population. Strength-based case management (SBCM) has shown strong effects on treatment linkage among patients with substance use disorders in other healthcare settings. This study aimed to investigate whether SBCM is an effective model for linking opioid-dependent ED patients with addiction treatment and pharmacotherapy. Here, we describe the implementation and challenges of adapting SBCM for the ED (SBCM-ED). Study rationale, design, and baseline characteristics are also described.

Methods

This study compared the effects of SBCM-ED to screening, assessment, and referral alone (SAR) on treatment linkage, substance use, and functioning. We recruited participants from a public hospital in NYC. Working alliance between case managers and participants and the feasibility of SBCM implementation were evaluated. Baseline data from the randomized sample were analyzed for group equivalency. Outcomes analyses are forthcoming.

Results

Three hundred adult participants meeting DSM-IV criteria for opioid dependence were randomly assigned to either SBCM, in which they received a maximum of six case management sessions within 90 days of enrollment, or SAR, in which they received a comprehensive referral list and pamphlet outlining drug use consequences. No significant differences were found between groups at baseline on demographic or substance use characteristics. All SAR participants and 92.6% of SBCM-ED participants initiated their assigned intervention. Over half of SBCM-ED first sessions occurred in the ED on the day of enrollment. Case managers developed a strong working alliance with SBCM-ED participants after just one session.

Conclusion

Interventions that exceed SBIRT were accepted by an opioid-dependent patient population seen in an urban medical ED. At the time of study funding, this trial was one of the first to focus specifically on this population in this challenging setting. The successful implementation of SBCM demonstrates its adaptability to the ED and may serve as a potential model for EDs seeking to adopt an intervention that overcomes the barrier between the ED encounter and more intensive treatment.

Trial registration

ClinicalTrials.gov NCT02586896. Registered on 27 October 2015.
Literature
1.
Substance Abuse Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2018.
2.
Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2015; 2017.
3.
Vivolo-Kantor AM, Seth P, Gladden RM, Mattson CL, Baldwin GT, Kite-Powell A, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses - United States, July 2016-September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279–85.PubMedPubMedCentral
4.
Volkow ND, Wargo EM. Overdose prevention through medical treatment of opioid use disorders. Ann Intern Med. 2018;169(3):190–2.PubMed
5.
Alford DP, LaBelle CT, Kretsch N, Bergeron A, Winter M, Botticelli M, et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011;171(5):425–31.
6.
Soeffing JM, Martin LD, Fingerhood MI, Jasinski DR, Rastegar DA. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year. J Subst Abus Treat. 2009;37(4):426–30.
7.
Roux P, Villes V, Blanche J, Bry D, Spire B, Feroni I, et al. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management. Drug Alcohol Depend. 2008;97(1–2):105–13.PubMed
8.
Fiellin DA, Moore BA, Sullivan LE, Becker WC, Pantalon MV, Chawarski MC, et al. Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. Am J Addict. 2008;17(2):116–20.PubMed
9.
Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Ann Fam Med. 2007;5(2):146–50.PubMedPubMedCentral
10.
Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2018;391(10118):309–18.PubMed
11.
Hawk K, D’Onofrio G. Emergency department screening and interventions for substance use disorders. Addict Sci Clin Pract. 2018;13(1):18.PubMedPubMedCentral
12.
D’Onofrio G, McCormack RP, Hawk K. Emergency departments — a 24/7/365 option for combating the opioid crisis. N Engl J Med. 2018;379(26):2487–90.PubMed
13.
Prevention CfDCa. 2018 Annual surveillance report of drug-related risks and outcomes — United States. Published online: August 31, 2018.; 2018.
14.
Samuels EA, Dwyer K, Mello MJ, Baird J, Kellogg AR, Bernstein E. Emergency department-based opioid harm reduction: moving physicians from willing to doing. Acad Emerg Med. 2016;23(4):455–65.PubMed
15.
Academic ED. SBIRT Research Collaborative. An evidence based alcohol screening, brief intervention and referral to treatment (SBIRT) curriculum for emergency department (ED) providers improves skills and utilization. Subst Abus. 2007;28(4):79–92.
16.
Davoudi M, Rawson RA. Screening, brief intervention, and referral to treatment (SBIRT) initiatives in California: notable trends, challenges, and recommendations. J Psychoactive Drugs. 2010;Suppl 6:239–48.
17.
Babor TF, Kadden RM. Screening and interventions for alcohol and drug problems in medical settings: what works? J Trauma. 2005;59(3 Suppl):S80–7.PubMed
18.
Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7–30.PubMed
19.
Agerwala SM, McCance-Katz EF. Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief review. J Psychoactive Drugs. 2012;44(4):307–17.PubMedPubMedCentral
20.
Collaborative AESR. The impact of screening, brief intervention, and referral for treatment on emergency department patients’ alcohol use. Ann Emerg Med. 2007;50(6):699–710.
21.
Collaborative AESR. The impact of screening, brief intervention and referral for treatment in emergency department patients’ alcohol use: a 3-, 6-and 12-month follow-up. Alcohol Alcohol. 2010;45(6):514–9.
22.
Havard A, Shakeshaft A, Sanson-Fisher R. Systematic review and meta-analyses of strategies targeting alcohol problems in emergency departments: interventions reduce alcohol-related injuries. Addiction. 2008;103(3):368–76.PubMed
23.
Bogenschutz MP, Donovan DM, Mandler RN, Perl HI, Forcehimes AA, Crandall C, et al. Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial brief intervention for drug-using ED patients brief intervention for drug-using ED patients. JAMA Intern Med. 2014;174(11):1736–45.PubMedPubMedCentral
24.
Rapp RC, Van Den Noortgate W, Broekaert E, Vanderplasschen W. The efficacy of case management with persons who have substance abuse problems: a three-level meta-analysis of outcomes. J Consult Clin Psychol. 2014;82(4):605–18.PubMed
25.
Shwartz M, Baker G, Mulvey KP, Plough A. Improving publicly funded substance abuse treatment: the value of case management. Am J Public Health. 1997;87(10):1659–64.PubMedPubMedCentral
26.
Hesse M, Vanderplasschen W, Rapp R, Broekaert E, Fridell M. Case management for persons with substance use disorders. Cochrane Database Syst Rev. 2007;4.
27.
Coviello DM, Zanis DA, Wesnoski SA, Alterman AI. The effectiveness of outreach case management in re-enrolling discharged methadone patients. Drug Alcohol Depend. 2006;85(1):56–65.PubMed
28.
Coviello DM, Zanis DA, Wesnoski SA, Alterman AI. The effectiveness of outreach case management in re-enrolling discharged methadone patients. Drug and alcohol dependence. 2006;85(1):56-65.
29.
Strathdee SA, Ricketts EP, Huettner S, Cornelius L, Bishai D, Havens JR, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol Depend. 2006;83(3):225–32.PubMed
30.
Scott CK, Sherman RE, Foss MA, Godley M, Hristova L. Impact of centralized intake on case management services. J Psychoactive Drugs. 2002;34(1):51–7.PubMed
31.
Rapp RC, Otto AL, Lane DT, Redko C, McGatha S, Carlson RG. Improving linkage with substance abuse treatment using brief case management and motivational interviewing. Drug Alcohol Depend. 2008;94(1–3):172–82.PubMedPubMedCentral
32.
Morgenstern J, Blanchard KA, McCrady BS, McVeigh KH, Morgan TJ, Pandina RJ. Effectiveness of intensive case management for substance-dependent women receiving temporary assistance for needy families. Am J Public Health. 2006;96(11):2016–23.PubMedPubMedCentral
33.
Vaughan-Sarrazin MS, Hall JA, Rick GS. Impact of case management on use of health services by rural clients in substance abuse treatment. J Drug Issues. 2000;30(2):435–63.
34.
Siegal HA, Rapp RC, Li L, Saha P, Kirk KD. The role of case management in retaining clients in substance abuse treatment: an exploratory analysis. J Drug Issues. 1997;27(4):821–32.
35.
Rapp RC, Siegal HA, Li L, Saha P. Predicting post-primary treatment services and drug use outcome: a multivariate analysis. Am J Drug Alcohol Abuse. 1998;24(4):603–15.PubMed
36.
Siegal HA, Li L, Rapp RC. Case management as a therapeutic enhancement: impact on post-treatment criminality. J Addict Dis. 2002;21(4):37–46.PubMed
37.
Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del RC, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423–31.PubMed
38.
Craw JA, Gardner LI, Marks G, Rapp RC, Bosshart J, Duffus WA, et al. Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr. 2008;47(5):597–606.PubMed
39.
Association AP. Diagnostic and statistical manual of mental disorders text revision. 4th ed. Washington, DC: American Psychiatric Press; 2000.
40.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
41.
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Informatics. 2019;95:103208.
42.
Westerberg VS, Tonigan JS, Miller WR. Reliability of form 90D: an instrument for quantifying drug use. Subst Abus. 1998;19(4):179–89.PubMed
43.
Miller WR, Del Boca FK. Measurement of drinking behavior using the form 90 family of instruments. J Stud Alcohol Suppl. 1994;12:112–8.PubMed
44.
The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–8.
45.
Simpson DD, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychother Theory Res Pract Train. 1993;30(2):357–68.
46.
Arthur I. Alterman JSC, Megan A. Ivey, Brian Habing, and Kevin G. Lynch. Reliability and validity of the alcohol short index of problems and a newly constructed drug short index of problems. J Stud Alcohol Drugs 2009;70(2):304–307.
47.
Richard C, Rapp JX, Carey A. Carr, D. Tim Lane, Jichuan Wang, Robert Carlson. Treatment barriers identified by substance abusers assessed at a centralized intake unit. J Subst Abus Treat. 2006;30(3):227–35.
48.
Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, et al. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine–naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug Alcohol Depend. 2009;99(1–3):28–36.PubMed
49.
Williamson A, Darke S, Ross J, Teesson M. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study. J Subst Abus Treat. 2007;33(3):287–93.
50.
Salamina G, Diecidue R, Vigna-Taglianti F, Jarre P, Schifano P, Bargagli AM, et al. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study. Subst Use Misuse. 2010;45(12):2076–92.PubMed
51.
Hesse M. The Beck Depression Inventory in patients undergoing opiate agonist maintenance treatment. J Clin Psychol. 2006;45(3):417–25.
52.
Siegal HA. Comprehensive case management for substance abuse treatment: SAMHSA; 1998.
53.
Ballew JR, Mink G. Case management in social work. Springfield: Charles C. Thomas; 1996.
54.
Rapp RC. Strengths-based case management: enhancing treatment for persons with substance abuse problems. Strengths Perspect Soc Work Pract. 2006;4:128–47.
55.
Redko C, Rapp RC, Elms C, Snyder M, Carlson RG. Understanding the working alliance between persons with substance abuse problems and strengths-based case managers. J Psychoactive Drugs. 2007;39(3):241–50.PubMed
56.
Bandura A. A social cognitive perspective on positive psychology. Rev Psicol Soc. 2011;26(1):7–20.
57.
Bandura A, Caprara GV, Barbaranelli C, Regalia C, Scabini E. Impact of family efficacy beliefs on quality of family functioning and satisfaction with family life. Appl Psychol. 2011;60(3):421–48.
58.
Bandura A, Kupers CJ. Transmission of patterns of self-reinforcement through modeling. J Abnorm Soc Psychol. 1964;69(1):1.
59.
Brun C, Rapp RC. Strengths-based case management: Individuals' perspectives on strengths and the case manager relationship. Soc Work. 2001;46(3):278–88.PubMed
60.
Barber J, Luborsky L, Crits-Christoph P, Thase M, Weiss R, Frank A, et al. Therapeutic alliance as a predictor of outcome in treatment of cocaine dependence. Psychother Res. 1999;9(1):54–73.
61.
Meier PS, Donmall MC, Barrowclough C, McElduff P, Heller RF. Predicting the early therapeutic alliance in the treatment of drug misuse. Addiction. 2005;100(4):500–11.PubMed
62.
Petry NM, Bickel WK. Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence. Psychiatr Serv. 1999;50(2):219–27.PubMed
63.
Hatcher RL, Gillaspy JA. Development and validation of a revised short version of the working alliance inventory. Psychother Res. 2006;16(1):12–25.
64.
Regis A, Meyers-Ohki S, Mennenga S, McCormack R, Rapp R, Greco P, Glisker R, Kolaric R, Bogenschutz M. Baseline characteristics of the sample enrolled in, “Comparing interventions for opioid-dependent patients presenting in medical EDs (ED-SBCM)". 81st Annual CPDD Scientific Meeting; June 16, 2019; San Antonio, Texas. 2019.
65.
Munder T, Wilmers F, Leonhart R, Linster HW, Barth J. Working Alliance Inventory-Short Revised (WAI-SR): psychometric properties in outpatients and inpatients. Clin Psychol Psychother. 2010;17(3):231–9.PubMed
66.
Jasper K, Weise C, Conrad I, Andersson G, Hiller W, Kleinstäuber M. The working alliance in a randomized controlled trial comparing Internet-based self-help and face-to-face cognitive behavior therapy for chronic tinnitus. Internet Interv. 2014;1(2):49–57.
Metadata
Title
Implementation of strength-based case management for opioid-dependent patients presenting in medical emergency departments: rationale and study design of a randomized trial
Authors
Amber Regis
Sarah E. Meyers-Ohki
Sarah E. Mennenga
Peter P. Greco
Richard Glisker
Rhonda Kolaric
Ryan P. McCormack
Richard C. Rapp
Michael P. Bogenschutz
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Opioids
Opioids
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04684-6

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Study protocol

An antibiotic stewardship programme to reduce inappropriate antibiotic prescribing for acute respiratory infections in rural Chinese primary care facilities: study protocol for a clustered randomised controlled trial

Study protocol

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

Study protocol

Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study

Study protocol

Sustainable, healthy cities: protocol of a mixed methods evaluation of a cluster randomized controlled trial for Aedes control in Brazil using a community mobilization approach

Research

Retaining participants in community-based health research: a case example on standardized planning and reporting

Letter

Letter on Update to the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Protocol